Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
With over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications.
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
With deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
Creative Biolabs is one of the world’s leading contract organizations (CRO) that has extensive experience in preclinical drug discovery. Our employees are at the core of our success, with the ambition to improving health and increasing access to quality health solutions worldwide. We believe when curious, courageous and collaborative people like you are brought together, a big difference will be made for the development of innovate medicines.
Get a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
PEGylated antibodygamma1 heavy chain fragment VH – (CH1-hinge) (1-229) [humanized VH (Homo sapiens IGHV3-74*01 (76.50%) – (IGHD) – IGHJ1*01) [8.7.12](1-118) Homo sapiens IGHG1*01 (CH1 (119-216), hinge 1 11 (217-227)) (119-227) – dialanyl (228-229)], (221-214') – disulfidekappa light chain (1'-214') [humanized V- KAPPA (Homo sapiens IGKV1-NL1*01 (83.20%) – IGKJ1*01) [6.3.9] (1'-107') – Homo sapiens IGKC*01(108'-214')];conjugated via a linker of the maleimide group (thioether bond with cysteinyl h 11 (227)) to two linear chains of methoxy polyethylene glycol20 (mPEG20).
Purity >95% by SDS-PAGE.
CD154, also called CD40 ligand or CD40L, is a protein that is primarily expressed on activated T cells and is a member of the TNF superfamily of molecules. It binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. In total CD40L has three binding partners: CD40, α5β1 integrin and αIIbβ3.